Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:35 pm Sale | 13G | Unity Biotechnology Inc. UBX | Alyeska Investment Group L.P. | 1,667,914 9.990% | -8,904 (-0.53%) | View |
| 2024-02-14 1:52 pm Purchase | 13G | Unity Biotechnology Inc. UBX | Alyeska Investment Group L.P. | 1,676,818 9.990% | 257,818 (+18.17%) | View |
| 2023-05-10 09:45 am Sale | 13G | Unity Biotechnology Inc. UBX | FMR LLC | 600,004 4.016% | -763,116 (-55.98%) | View |
| 2023-02-14 2:07 pm Purchase | 13G | Unity Biotechnology Inc. UBX | Alyeska Investment Group L.P. | 1,419,000 9.990% | 1,419,000 (New Position) | View |
| 2023-02-09 12:39 pm Purchase | 13G | Unity Biotechnology Inc. UBX | FMR LLC | 1,363,120 9.215% | 1,363,120 (New Position) | View |
| 2022-10-11 09:03 am Purchase | 13G | Unity Biotechnology Inc. UBX | FMR LLC | 13,543,215 9.658% | 220,000 (+1.65%) | View |
| 2022-09-12 11:13 am Purchase | 13G | Unity Biotechnology Inc. UBX | FMR LLC | 13,323,215 14.975% | 10,216,685 (+328.88%) | View |
| 2022-02-14 4:12 pm Unchanged | 13G | Unity Biotechnology Inc. UBX | Venrock Associates VII L.P. | 2,680,039 4.600% | 0 (Unchanged) | View |
| 2022-02-11 4:55 pm Purchase | 13G | Unity Biotechnology Inc. UBX | ARCH Venture Fund VII L.P. | 10,138,859 17.500% | 38,560 (+0.38%) | View |
| 2022-02-09 10:01 am Sale | 13G | Unity Biotechnology Inc. UBX | FMR LLC | 3,106,530 5.381% | -1,477,087 (-32.23%) | View |
| 2021-07-01 11:12 am Sale | 13G | Unity Biotechnology Inc. UBX | BAILLIE GIFFORD & CO | 2,479,068 4.520% | -1,323,946 (-34.81%) | View |
| 2021-06-09 2:01 pm Sale | 13G | Unity Biotechnology Inc. UBX | BlackRock Inc. BLK | 2,711,482 4.900% | -170,171 (-5.91%) | View |
| 2021-02-08 10:35 am Sale | 13G | Unity Biotechnology Inc. UBX | FMR LLC | 4,583,617 8.662% | -267,372 (-5.51%) | View |
| 2021-02-02 5:03 pm Purchase | 13G | Unity Biotechnology Inc. UBX | ARCH Venture Fund VII L.P. | 10,100,299 19.100% | 38,559 (+0.38%) | View |
| 2021-02-02 2:56 pm Purchase | 13G | Unity Biotechnology Inc. UBX | BlackRock Inc. BLK | 2,881,653 5.400% | 2,881,653 (New Position) | View |
| 2021-01-14 12:29 pm Unchanged | 13G | Unity Biotechnology Inc. UBX | BAILLIE GIFFORD & CO | 3,803,014 7.190% | 0 (Unchanged) | View |
| 2021-01-08 4:49 pm Purchase | 13G | Unity Biotechnology Inc. UBX | WuXi PharmaTech Healthcare Fund I L.P. | 1,477,987 2.800% | 1,477,987 (New Position) | View |
| 2020-02-13 4:51 pm Purchase | 13G | Unity Biotechnology Inc. UBX | ARCH Venture Fund VII L.P. | 10,061,740 21.900% | 13,559 (+0.13%) | View |
| 2020-02-11 5:22 pm Purchase | 13G | Unity Biotechnology Inc. UBX | David Nathaniel E | 2,372,160 5.150% | 66,386 (+2.88%) | View |
| 2020-02-07 11:32 am Purchase | 13G | Unity Biotechnology Inc. UBX | FMR LLC | 4,850,989 10.558% | 509,466 (+11.73%) | View |